Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization.
Jonathan CorrenNicola A HananiaWilliam W BusseLawrence D SherArman AltincatalMegan HardinLeda P MannentNikhil AminDavid J LedererXavier SolerJuby A Jacob-NaraPaul J RoweYamo DenizPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)
Dupilumab demonstrated efficacy during prolonged treatment in patients with uncontrolled, moderate-to-severe asthma with FS.
Keyphrases